A Leap Forward in Asthma Management with AI

By HEOR Staff Writer

January 2, 2024

The Asthma Challenge

The chronic disease known as asthma, which is characterised by inflammation of the airways, affects between 10 and 12 percent of children around the world and a sizeable percentage of adults. It is the ailment that affects children the most frequently and is a big contributor to the burden of health problems all around the world. In order to alleviate the enormous physical and financial burden that asthma exacerbations impose, it is essential to diagnose the condition at an early stage and to manage it effectively.

The Role of Artificial Intelligence in Asthma Management

The use of artificial intelligence (AI) in healthcare has been a topic of interest for the past few years as this could be utilised to manage or prevent several diseases. Research on the AI-assisted home stethoscope, StethoMe, reveals its potential for detecting and monitoring asthma, particularly in children. This device can identify pathological auscultatory phenomena. It also measures parameters like heart rate, respiratory rate, and the ratio of inspiration-to-expiration duration.

AI-aided Stethoscope: A Game Changer in Asthma Monitoring

The study found that the parameters provided by the AI-aided stethoscope alone were highly efficient in identifying asthma exacerbation in children. This indicates that AI-aided stethoscopes can facilitate the detection of exacerbations with high effectiveness. Even in children younger than five years of age. This is a significant advancement as asthma management in children is challenging due to the limitations of conducting standard physiologic tests.

The Future of AI in Asthma Management

The use of AI-aided stethoscopes in asthma management aligns with the shift towards value-based healthcare. AI-aided stethoscopes are a useful tool that can optimise and improve patient-doctor collaboration using telemedicine solutions. They also have the potential to improve asthma-related health outcomes, increase access to care, and offer cost-effectiveness. The study indicates that home stethoscopes, aided by AI, could simplify asthma diagnosis. They could monitor a wider range of parameters and significantly ease the process of asthma monitoring.

Reference url

Recent Posts

Joint Scientific Consultation EU
Joint Scientific Consultation EU Strategies for Medical Device Companies

By João L. Carapinha

June 19, 2026

The EU Joint Scientific Consultation gives medical device developers a voluntary route to obtain targeted feedback on clinical evidence plans well before formal Joint Clinical Assessment and national reimbursement decisions. Manufacturers of select high-risk technologies can align their developme...
EU Joint Clinical Assessment
Insights on EU Joint Clinical Assessment for High-Risk Medical Devices

By João L. Carapinha

June 19, 2026

EU Joint Clinical Assessment is a distinct, harmonised process that operates separately from CE marking. It produces comparative clinical evidence on selected high-risk devices to support more consistent national reimbursement decisions across EU member states. Insights from the
LesionAttn Skin Cancer AI
LesionAttn Skin Cancer AI Enhances Fairness in Dermatological Diagnostics

By João L. Carapinha

June 19, 2026

LesionAttn Skin Cancer AI tackles a critical flaw in current skin cancer detection tools: models that unconsciously rely on background skin features differing between men and women, producing unequal accuracy across genders. By steering neural networks to focus on the actual lesion instead of the...